Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Nationwide Children's Hospital, Columbus, Ohio, United States
Gentofte Hospital, Copenhagen, Denmark
Northern Orthopaedic Division, Clinik Farsoe, Aalborg University Hospital, Farsoe, Northern Jutland, Denmark
University of New Mexico Hospital, Albuquerque, New Mexico, United States
University Hospital of North Norway, Tromsø, Troms, Norway
St. Antonius Hospital, Nieuwegein, Netherlands
Aleris-Hamlet Hospital, Frederiksberg, Denmark
Mayo Clinic in Arizona, Phoenix, Arizona, United States
Piracicaba Dental School, Piracicaba, São Paulo, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.